Total Payments
$2.2M
2024 Payments
$28,908
Companies
14
Transactions
135
Medicare Patients
628
Medicare Billing
$55,137
Payment Breakdown by Category
Royalty/License$2.1M (96.1%)
Consulting$59,480 (2.7%)
Research$14,500 (0.7%)
Travel$10,539 (0.5%)
Food & Beverage$1,119 (0.1%)
Other$640.00 (0.0%)
Gifts$73.60 (0.0%)
Education$48.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $2.1M | 5 | 96.1% |
| Consulting Fee | $59,480 | 21 | 2.7% |
| Unspecified | $14,500 | 3 | 0.7% |
| Travel and Lodging | $10,539 | 53 | 0.5% |
| Food and Beverage | $1,119 | 35 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $640.00 | 15 | 0.0% |
| Gift | $73.60 | 1 | 0.0% |
| Education | $48.27 | 2 | 0.0% |
Payments by Type
General
$2.2M
132 transactions
Research
$14,500
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CurveBeam LLC | $2.1M | 5 | $0 (2022) |
| Pacira Pharmaceuticals Incorporated | $53,370 | 93 | $0 (2024) |
| Integra LifeSciences Corporation | $24,666 | 5 | $0 (2022) |
| Flexion Therapeutics, Inc. | $2,533 | 4 | $0 (2019) |
| TRICE MEDICAL, INC. | $2,392 | 4 | $0 (2024) |
| Tenex Health Inc. | $1,000 | 1 | $0 (2021) |
| Derma Sciences, Inc. | $755.31 | 2 | $0 (2019) |
| Arthrex, Inc. | $750.00 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $540.00 | 14 | $0 (2017) |
| Siemens Medical Solutions USA, Inc. | $149.77 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,908 | 50 | Pacira Pharmaceuticals Incorporated ($26,888) |
| 2023 | $24,943 | 46 | Pacira Pharmaceuticals Incorporated ($23,868) |
| 2022 | $2.1M | 9 | CurveBeam LLC ($2.1M) |
| 2021 | $14,750 | 3 | Integra LifeSciences Corporation ($13,750) |
| 2019 | $973.89 | 7 | Derma Sciences, Inc. ($755.31) |
| 2018 | $2,548 | 3 | Flexion Therapeutics, Inc. ($2,508) |
| 2017 | $789.77 | 17 | SANOFI-AVENTIS U.S. LLC ($540.00) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $4,180.00 | General |
| Category: Pain Management | ||||||
| 11/21/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $523.75 | General |
| Category: Pain Management | ||||||
| 11/21/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $179.38 | General |
| Category: Pain Management | ||||||
| 11/21/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $69.00 | General |
| Category: Pain Management | ||||||
| 11/21/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $29.90 | General |
| Category: Pain Management | ||||||
| 11/21/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: Pain Management | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $3,420.00 | General |
| Category: Pain Management | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $649.21 | General |
| Category: Pain Management | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $279.51 | General |
| Category: Pain Management | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $69.00 | General |
| Category: Pain Management | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Pain Management | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $53.93 | General |
| Category: Pain Management | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | Cash or cash equivalent | $6.48 | General |
| Category: Pain Management | ||||||
| 11/12/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $59.70 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $53.24 | General |
| Category: Pain Management | ||||||
| 11/10/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Pain Management | ||||||
| 11/09/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | In-kind items and services | $217.14 | General |
| Category: Pain Management | ||||||
| 09/23/2024 | TRICE MEDICAL, INC. | — | Food and Beverage | Cash or cash equivalent | $43.00 | General |
| 09/12/2024 | Arthrex, Inc. | Arthrex (Biological) | — | Cash or cash equivalent | $750.00 | Research |
| Study: ACP Max (AICS/600) • Category: Biologics - Consumables - Autologous Cellular Products - ACP PRP | ||||||
| 08/27/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $4,940.00 | General |
| Category: Pain Management | ||||||
| 08/27/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | Cash or cash equivalent | $517.88 | General |
| Category: Pain Management | ||||||
| 08/27/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $254.60 | General |
| Category: Pain Management | ||||||
| 08/27/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | Cash or cash equivalent | $69.00 | General |
| Category: Pain Management | ||||||
| 08/27/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Pain Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| T-MAMSKO-01 | Integra LifeSciences Corporation | $13,750 | 2 |
| ACP Max (AICS/600) | Arthrex, Inc. | $750.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 161 | 264 | $89,542 | $15,614 |
| 2022 | 6 | 165 | 222 | $44,945 | $12,556 |
| 2021 | 7 | 171 | 256 | $80,507 | $14,523 |
| 2020 | 6 | 131 | 193 | $74,541 | $12,444 |
Total Patients
628
Total Services
935
Medicare Billing
$55,137
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 64 | $11,438 | $3,866 | 33.8% |
| 64640 | Destruction of peripheral nerve or branch | Facility | 2023 | 16 | 55 | $46,810 | $3,787 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 40 | $7,246 | $2,675 | 36.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Facility | 2023 | 19 | 39 | $15,009 | $2,000 | 13.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $3,764 | $1,421 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 25 | $3,416 | $1,257 | 36.8% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 20 | 26 | $1,859 | $609.70 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 43 | $7,310 | $2,313 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 24 | $3,752 | $1,801 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 25 | $3,825 | $1,751 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 13 | 13 | $3,172 | $1,312 | 41.3% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Facility | 2022 | 14 | 23 | $9,061 | $1,293 | 14.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,618 | $1,019 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 21 | $2,793 | $1,017 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 23 | $2,990 | $927.94 | 31.0% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 16 | 25 | $8,456 | $790.49 | 9.3% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 12 | 14 | $968.00 | $332.42 | 34.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 58 | $7,608 | $2,757 | 36.2% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2021 | 14 | 41 | $36,864 | $2,550 | 6.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $6,519 | $2,443 | 37.5% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 25 | 48 | $17,175 | $2,271 | 13.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 27 | $4,280 | $2,049 | 47.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 36 | $6,240 | $1,991 | 31.9% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 18 | 19 | $1,821 | $463.03 | 25.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 30 | 58 | $9,119 | $3,279 | 36.0% |
About Dr. Neil Segal, MD
Dr. Neil Segal, MD is a Dermatology healthcare provider based in Iowa City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407848880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neil Segal, MD has received a total of $2.2M in payments from pharmaceutical and medical device companies, with $28,908 received in 2024. These payments were reported across 135 transactions from 14 companies. The most common payment nature is "Royalty or License" ($2.1M).
As a Medicare-enrolled provider, Segal has provided services to 628 Medicare beneficiaries, totaling 935 services with total Medicare billing of $55,137. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Physical Medicine & Rehabilitation
- Location Iowa City, IA
- Active Since 08/22/2005
- Last Updated 07/24/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1407848880
Products in Payments
- Iovera (Device) $44,285
- ACELL (Medical Supply) $13,750
- BIODRESTORE (Device) $11,555
- Exparel (Drug) $6,524
- Zilretta (Drug) $5,093
- Arthrex (Biological) $750.00
- SYNVISC-ONE (Device) $540.00
- MAGNETOM Vida 3T (Device) $149.77
- BIOFIX (Device) $115.96
- Nstride (Device) $40.00
- Dysport (Drug) $27.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Iowa City
Ali Jabbari, Md, Phd, MD, PHD
Dermatology — Payments: $36,417
Dermatology $36,417
Dr. Nicole Negbenebor, Md, MD
Dermatology — Payments: $14,430
Dermatology $14,430
Deborah Huebbe Youhn, Md, MD
Dermatology — Payments: $3,870
Dermatology $3,870
Dr. Janet Fairley, Md, MD
Dermatology — Payments: $3,843
Dermatology $3,843
Dr. Pooja Chitgopeker, M.d, M.D
Dermatology — Payments: $2,875
Dermatology $2,875
Dr. Heather Ciliberto, Md, MD
Dermatology — Payments: $757.59
Dermatology $757.59